Prognostic value of long non-coding RNA CRNDE in gastrointestinal cancers: a meta-analysis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2017;67(2):100–121. doi:10.3322/caac.2139228170086
   PubMed Web of Science ®Google Scholar
• Wyld L, Audisio RA, Poston GJ. The evolution of cancer surgery and future perspectives. Nat Rev Clin Oncol. 2015;12(2):115–124. doi:10.1038/nrclinonc.2014.19125384943
   PubMed Web of Science ®Google Scholar
• Kang YK, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461–2471. doi:10.1016/S0140-6736(17)31827-528993052
   PubMed Web of Science ®Google Scholar
• Valle JW, Lamarca A, Goyal L, Barriuso J, Zhu AX. New horizons for precision medicine in biliary tract cancers. Cancer Discov. 2017;7(9):943–962. doi:10.1158/2159-8290.CD-17-024528818953
   PubMed Web of Science ®Google Scholar
• Adiseshaiah PP, Crist RM, Hook SS, McNeil SE. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nat Rev Clin Oncol. 2016;13(12):750–765. doi:10.1038/nrclinonc.2016.11927531700
   PubMed Web of Science ®Google Scholar
• Ulitsky I. Evolution to the rescue: using comparative genomics to understand long non-coding RNAs. Nat Rev Genet. 2016;17(10):601–614. doi:10.1038/nrg.2016.8527573374
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391–407. doi:10.1158/2159-8290.CD-11-020922096659
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463. doi:10.1016/j.ccell.2016.03.01027070700
   PubMed Web of Science ®Google Scholar
• Jiang H, Wang Y, Ai M, et al. Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways. Cell Death Dis. 2017;8(6):e2862. doi:10.1038/cddis.2017.51828594403
   PubMedGoogle Scholar
• Hu CE, Du PZ, Zhang HD, Huang GJ. Long noncoding RNA CRNDE promotes proliferation of gastric cancer cells by targeting miR-145. Cell Physiol Biochem. 2017;42(1):13–21. doi:10.1159/00047710728490034
   PubMedGoogle Scholar
• Zheng J, Liu X, Wang P, et al. CRNDE promotes malignant progression of glioma by attenuating miR-384/PIWIL4/STAT3 axis. Mol Ther. 2016;24(7):1199–1215. doi:10.1038/mt.2016.7127058823
   PubMed Web of Science ®Google Scholar
• Ji D, Jiang C, Zhang L, et al. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/BCAT1 axis. J Cell Physiol. 2018;234(5):6548–6560. doi:10.1002/jcp.27396
   Web of Science ®Google Scholar
• Liu T, Zhang X, Yang YM, et al. Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression. Onco Targets Ther. 2016;9:1437–1448. doi:10.2147/OTT.S9826827042112
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang X, Gao S, et al. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget. 2016;7(51):85551–85563. doi:10.18632/oncotarget.1346527888803
   PubMed Web of Science ®Google Scholar
• Han P, Li JW, Zhang BM, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/beta-catenin signaling. Mol Cancer. 2017;16(1):9. doi:10.1186/s12943-017-0583-128086904
   PubMed Web of Science ®Google Scholar
• Ding J, Li J, Wang H, et al. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression. Cell Death Dis. 2017;8(8):e2997. doi:10.1038/cddis.2017.51828796262
   PubMed Web of Science ®Google Scholar
• Li Y, Huang W, Liu J, et al. The predictive value of serum lncRNA CRNDE for efficacy of first-line FOLFOX chemotherapy in patients with metastatic colorectal cancer and their prognosis. Dept Oncol. 2018;16(07):897–900+916.
   Google Scholar
• Du DX, Lian DB, Amin BH, Yan W. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer. Eur Rev Med Pharmacol Sci. 2017;21(23):5392–5398. doi:10.26355/eurrev_201712_1392529243780
   PubMed Web of Science ®Google Scholar
• Wang G, Pan J, Zhang L, Li Q, Tao Z, Lin Y. Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1. Cell Prolif. 2017;50(6). doi:10.1111/cpr.12368
   Web of Science ®Google Scholar
• Xia XL, Xue D, Xiang TH, et al. Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma. Oncol Lett. 2018;15(4):4105–4112. doi:10.3892/ol.2018.781529556285
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi:10.1186/1745-6215-8-1617555582
   PubMed Web of Science ®Google Scholar
• Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815–2834.9921604
   PubMed Web of Science ®Google Scholar
• Lin C, Yang L. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol. 2018;28(4):287–301. doi:10.1016/j.tcb.2017.11.00829274663
   PubMed Web of Science ®Google Scholar
• Zhang M, Gao C, Yang Y, et al. Long noncoding RNA CRNDE/PRC2 participated in the radiotherapy resistance of human lung adenocarcinoma through targeting p21 expression. Oncol Res. 2018;26(8):1245–1255. doi:10.3727/096504017X1494458587366828550688
   PubMed Web of Science ®Google Scholar
• Qu L, Ding J, Chen C, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29(5):653–668. doi:10.1016/j.ccell.2016.03.00427117758
   PubMed Web of Science ®Google Scholar
• Xie H, Ma B, Gao Q, et al. Long non-coding RNA CRNDE in cancer prognosis: review and meta-analysis. Clin Chim Acta. 2018;485:262–271. doi:10.1016/j.cca.2018.07.00330008427
   PubMed Web of Science ®Google Scholar
• Liang C, Zhang B, Ge H, Xu Y, Li G, Wu J. Long non-coding RNA CRNDE as a potential prognostic biomarker in solid tumors: a meta-analysis. Clin Chim Acta. 2018;481:99–107. doi:10.1016/j.cca.2018.02.03929501692
   PubMed Web of Science ®Google Scholar
• Yu B, Ye X, Du Q, et al. The long non-coding RNA CRNDE promotes colorectal carcinoma progression by competitively binding miR-217 with TCF7L2 and enhancing the wnt/beta-catenin signaling pathway. Cell Physiol Biochem. 2017;41(6):2489–2502. doi:10.1159/00047594128472810
   PubMedGoogle Scholar
• Gao H, Song X, Kang T, et al. Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer. Oncol Targets Ther. 2017;10:205–216. doi:10.2147/OTT.S116178
   PubMed Web of Science ®Google Scholar
• Chen Z, Yu C, Zhan L, Pan Y, Chen L, Sun C. LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. Am J Cancer Res. 2016;6(10):2299–2309.27822419
   PubMed Web of Science ®Google Scholar
• Wang H, Ke J, Guo Q, Barnabo Nampoukime K-P, Yang P, Ma K. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis. J Cell Mol Med. 2018;22:5862–5876. doi:10.1111/jcmm.2018.22.issue-1230246921
   PubMed Web of Science ®Google Scholar